ClinicalTrials.gov
ClinicalTrials.gov Menu

Study on Correlation Between Vascular ET-1 and Adiponectin in Pediatric Obesity

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01750333
Recruitment Status : Unknown
Verified December 2012 by Monica Montagnani, Montagnani, Monica, M.D., Ph.D..
Recruitment status was:  Active, not recruiting
First Posted : December 17, 2012
Last Update Posted : December 17, 2012
Sponsor:
Information provided by (Responsible Party):
Monica Montagnani, Montagnani, Monica, M.D., Ph.D.

Brief Summary:
The aim of this study is to explore whether and how high circulating levels of endothelin-1 (ET-1) in obese and overweight children may contribute to impair adiponectin (Ad) production, release and vascular activity

Condition or disease
OBESITY Endothelial Dysfunction Insulin Resistance

Study Type : Observational
Estimated Enrollment : 60 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Observational Retrospective Study on Correlation Between ET-1 and Ad in Obese Children
Study Start Date : April 2012
Estimated Primary Completion Date : March 2013
Estimated Study Completion Date : March 2013

Group/Cohort
Lean children
Overweight Children (OW)
Obese children (Ob)



Primary Outcome Measures :
  1. Correlation between serum levels of ET-1 and Ad in lean, overweight and obese children [ Time Frame: 12 months ]

Biospecimen Retention:   Samples Without DNA
  • serum
  • plasma


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   5 Years to 13 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
CHILDREN ATTENDING THE OUTPATIENT UNIT OF THE UNIVERSITY PEDIATRIC CLINIC
Criteria

Inclusion Criteria:

  • Children will be enrolled into lean, overweight or obese groups based on Body mass index (BMI) calculated according to standard methods. International standards for sex-and age-specific BMI centiles for subjects aged 2-18 years will be used. The 95th centile of BMI reference is the cut off point for childhood obesity. Overweight and obese children are defined as those with a BMI higher than the centile curves.

Exclusion Criteria:

  • presence of renal, liver and/or cardiovascular diseases;
  • hypertension;
  • metabolic and/or endocrine disorders;
  • genetic syndromes;
  • histories of chronic allergies, acute infectious or inflammatory diseases during the last 3 months preceding the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01750333


Locations
Italy
University of Bari Medical School - Dept Biomedical Sciences and Human Oncology
Bari, Italy, 70124
Sponsors and Collaborators
Monica Montagnani
Investigators
Principal Investigator: Monica Montagnani, MD, PhD University of Bari Medical School

Responsible Party: Monica Montagnani, Medical School Faculty Member - Professor of Pharmacology, Montagnani, Monica, M.D., Ph.D.
ClinicalTrials.gov Identifier: NCT01750333     History of Changes
Other Study ID Numbers: OBETAD-01
First Posted: December 17, 2012    Key Record Dates
Last Update Posted: December 17, 2012
Last Verified: December 2012

Additional relevant MeSH terms:
Obesity
Insulin Resistance
Overnutrition
Nutrition Disorders
Overweight
Body Weight
Signs and Symptoms
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases